Document:

EX-10.19

 Exhibit 10.19 

AMENDED AND RESTATED SERVICES AGREEMENT 

This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of
August 20, 2018, by and among Roivant Sciences GmbH., a company with limited liability organized under the laws of Switzerland (the “Service Provider”) and Dermavant Sciences GmbH, a company with limited liability organized
under the laws of Switzerland (“DSG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”). 

RECITALS 

WHEREAS, DSG is a biopharmaceutical company focused on acquiring, developing and commercializing late-stage dermatology drug
candidates, including non-strategic dermatology assets from large pharmaceutical companies, distressed dermatology drug candidates from small biotechnology companies, dermatology drugs or novel approaches from
universities, and high-risk dermatology projects abandoned by conventional biopharmaceutical firms; 
 WHEREAS, Service
Provider is capable of providing preparatory services in relation to the identification of potential dermatology drug asset candidates, managing the performance of clinical trials or other research and development activities, performing or
evaluating scientific and statistical analyses, and various administrative matters; 
 WHEREAS, Service Provider and DSG
entered into that certain Services Agreement, effective as of October 24, 2016 (the “Original Services Agreement”), pursuant to which DSG engaged the services of Service Provider in consideration for a fee; 

WHEREAS, the Parties hereto desire to amend and restate the Original Services Agreement in its entirety as set forth herein;
and 
 WHEREAS, DSG desires to continue to engage the services of Service Provider, and the Service Provider is willing to
provide such services in consideration for a fee. 
 NOW, THEREFORE, in consideration of the mutual covenants, rights and
obligations set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	 DEFINITIONS 

  

	1.1	 Additional Service Recipient. “Additional Service Recipient” shall mean any Affiliate of
Service Recipient who executes a joinder with the Service Provider, in a form provided by the Service Provider pursuant to which such Affiliate joins as a party to this Agreement and the Service Provider agrees to such joinder.

  

	1.2	 Affiliate. “Affiliate” shall mean any Person, whether de jure or de facto, other than a
Party, that directly or indirectly owns, is owned by or is under common ownership with a Party to the extent of at least fifty (50) percent of the equity having the power to vote on or direct the affairs of the entity, and any Person actually
controlled by, controlling, or under common control with a Party. 

  

	1.3	 Confidential Information. “Confidential Information” includes any information or materials
in any form or format owned or controlled by the disclosing party, or entrusted to it by others, including, but not limited to, inventions, technology, formulas, processes, technical data, prototypes, biological or other specimens, unpublished
patent applications, research results or plans, notes and notebooks, product or development plans, test results or protocols, market research or analysis, 

  
 1 

 marketing plans, regulatory information, business plans, personnel data,
customer or prospects lists, existing or anticipated agreements or relationships with Third Parties, and financial information, that is marked as “proprietary,” or “confidential,” or which would, under the circumstances (even
without any such markings), be understood by a reasonable person to be proprietary and nonpublic. Any data generated by Service Provider in connection with the Services will be treated as Confidential Information of the applicable Service Recipient.

  

	1.4	 Costs. “Costs” shall mean the fully-burdened cost incurred by the Service Provider and its
Affiliates during any applicable month to provide the Services. For purposes of this definition, the fully-burdened cost includes without limitation: (i) the costs of any materials used in providing the Services; (ii) the salary, benefits
(if any) (including without limitation, medical plans and 401(k) or other retirement plans), and employment taxes (if any) of all the Service Provider’s employees involved in providing such services (excluding, however, any compensation that is
provided to an employee or independent contractor in the form of equity instruments, options to acquire stock (stock options), rights with respect to (or determined by reference to) equity instruments or stock options, or any non-cash compensation provided by a third party to an employee or independent contractor); (iii) related overhead expenses (including, without limitation, cost of facilities and utilities costs, insurance, and the
cost of all general support, operational and business services); (iv) any and all licensing fees paid or payable to Third Parties for any intellectual property incorporated into such services; and (v) any depreciation, amortization or other
cost recovery for financial accounting purposes related to assets of the Service Provider to the extent such assets are used in providing the Services; provided, however, that the fully-burdened cost shall not include costs incurred by the Service
Provider to engage a Third Party for the purpose of providing Services pursuant to Section 3.4 of the Agreement. 

  

	1.5	 Effective Date. “Effective Date” shall mean, with respect to DSG, the date hereof, and with
respect to any Additional Service Recipient, the date of full execution of its joinder. 

  

	1.6	 General Works. “General Works” shall mean any Works or portion(s) thereof (including any
models, formats, processes, data, databases, software (whether in source code or object code), or algorithms) that both (i) do not directly relate to any of Service Recipient or its Affiliate’s drug products’ or portfolio
candidates’ intellectual property (including any formulation(s), specification(s), dosage(s), indication(s), delivery mechanism(s), manufacturing, development, or commercialization thereof), and (ii) have general applicability to the
operation of the business of the Service Provider (including for the purposes of undertaking analytics or improving or enhancing any of the Services or any other services of the Service Provider). 

 

	1.7	 Government Authority. “Government Authority” shall mean any United States or non-United States federal, national, state, territory, provincial or local court, arbitral tribunal, administrative agency or commission or other governmental or quasi-governmental authority of any nature (including
any governmental agency, branch, department, official, or entity and any court or other tribunal), including any regulatory agency or authority, any securities exchange and any organization or body exercising, or entitled exercise, any
administrative, executive, judicial, legislative, police, regulatory or taxing authority or power of any nature. 

  

	1.8	 Marks. “Marks” shall mean and include trademarks, service marks, trade names, domain names,
trade dress, logos, and similar designations, whether registered or unregistered, and all applications and registrations therefor. 

  

	1.9	 Party. “Party” shall mean either the Service Provider or any of the Service Recipients,
individually, and “Parties” shall mean the Service Provider and the Service Recipients collectively. 

  
 2 

	1.10	 Person. “Person” shall mean and include any individual, corporation, trust, estate,
partnership, joint venture, company, association, Government Authority, or any other entity regardless of the type or nature thereof. 

  

	1.11	 Representatives. “Representatives” shall mean the directors, officers, managers, members,
employees, agents, partners, service providers, existing or potential financing sources, existing or potential investors, and advisors of a Party and its Affiliates (including, without limitation, attorneys, accountants, consultants, and financial
advisors) that receive Confidential Information or have Confidential Information made available to them. 

  

	1.12	 Securities Laws. “Securities Laws” shall mean the Securities Act of 1933 (15 U.S.C. §
77), the Securities Exchange Act of 1934 (15 U.S.C. § 78), the Investment Company Act of 1940 (15 U.S.C. § 80a), and any regulations promulgated thereunder. 

 

	1.13	 Service Recipient Works. “Service Recipient Works” shall mean any Works that both
(i) relate to intellectual property or potential intellectual property originating from research and development of any Service Recipient or its Affiliate’s drug products or portfolio candidates, and (ii) arise out of Services
provided directly or indirectly (e.g., through an employee, consultant clinical research organization, other vendor or other Third Party engaged by the Service Provider) in connection with such research and development. For clarity, Service
Recipient Works shall not include any General Works. 

  

	1.14	 Third Party. “Third Party” shall mean any Person other than a Party or an Affiliate of a
Party. 

  

	1.15	 Dermavant Disclosure. “Dermavant Disclosure” shall mean (i) any disclosure of
information that any Service Recipient is required to make under the Securities Laws or any other laws or regulations obligating such Service Recipient to disclose information or (ii) any document, financial report, or other materials that any
Service Recipient files with the Securities and Exchange Commission or any other Government Authority. 

  

	1.16	 Works. “Works” shall mean any work product, technical knowledge, creations, know-how, formulations, recipes, specifications, rights, devices, drawings, instructions, expertise, trade practices, customer lists, computer data, software (whether in source code or object code),
algorithms, analytical and quality data, Marks, copyrights, commercial information, inventions, works of authorship, designs, methods, processes, technology, patterns, techniques, data, patents, trade secrets, related contracts, licenses and
agreements and the like, and all other intellectual property, in each case, created, authored, composed, or invented by the Service Provider, whether solely or jointly with others, whether patented, patentable or not, whether in written form or
otherwise, in performing the Services or any other of Service Provider’s obligations under this Agreement. 

  

	1.17	 Year. “Year” shall mean the 12-month period ending
on March 31. 

  

	2.	 ENGAGEMENT 

  

	2.1	 Subject to the terms of this Agreement, the Service Recipients hereby engage the Service Provider to perform
the services it requires from among those set forth on Exhibit A attached hereto (the “Services”). Any additional services requested by the Service Recipients that are not included within the Services shall, if mutually
agreed upon by the Parties, each in its sole discretion, be negotiated and included in this Agreement through written amendments to Exhibit A hereto. The scope of the Service Provider’s authority shall be specifically limited to those
activities outlined in this Agreement. 

  
 3 

	2.2	 Each Service Recipient agrees to provide reasonable assistance to, and to cooperate reasonably and in good
faith with, the Service Provider with respect to the performance and receipt of the Services. Each Service Recipient shall perform (or cause to be performed) such actions and deliver (or cause to be delivered) to the Service Provider such reports,
information, and other materials, in each case, as reasonably requested by the Service Provider in furtherance of the performance of the Services or as otherwise necessary for the Service Provider to perform the Services in an effective manner or to
comply with any obligations imposed on it under applicable law or by any Government Authority. Without limiting the foregoing, each Service Recipient will (and will cause its Affiliates to) cooperate with, and provide reasonable assistance to, the
Service Provider in connection with any communications with or investigations, inquiries, audits, or other requests for information issued by any Government Authority. 

 

	2.3	 Each Service Recipient acknowledges and agrees that the Service Provider’s performance of the Services
is subject to the cooperation of such Service Recipient and the timely performance of certain actions and timely delivery of certain reports, information, and other materials by such Service Recipient necessary to enable the performance of the
Services. In furtherance of the foregoing, each Service Recipient agrees that the Service Provider shall not be deemed to be in breach of any of its obligations hereunder to the extent that any failure of the Service Provider to perform such
obligations is caused by any failure or delay of a Service Recipient in such performance or delivery. 

  

	2.4	 Each Service Recipient agrees with the Service Provider that such Service Recipient shall not, and shall
cause its Affiliates not to, resell any of the Services to any Person whatsoever or to permit the use of the Services by any Person otherwise than as expressly contemplated by this Agreement or expressly agreed in advance in writing by the Service
Provider. 

  

	3.	 RELATIONSHIP OF THE PARTIES 

 

	3.1	 The Service Provider, on one hand, and each Service Recipient, on the other hand, are each independent
contractors and not joint venturers, partners, agents, or representatives of the other. The Service Provider shall perform the Services for the Service Recipients under this Agreement as an independent contractor and neither the Service Provider nor
its employees, subcontractors or agents shall be deemed to be agents, servants or employees of any Service Recipient, nor shall the Service Provider and any Service Recipient be deemed or construed solely by this Agreement to be partners or joint
venturers. The Service Provider shall have exclusive control over the direction and conduct of its employees in carrying out the activities required under this Agreement. 

 

	3.2	 Neither the Service Provider nor its employees, subcontractors or agents shall have the authority to (i)
negotiate the terms of or execute contracts and agreements of any Service Recipient outside of agreed guidelines, except as agreed pursuant to this Agreement or other arrangements, or in furtherance of the purposes and activities contained herein or
therein; (ii) hire personnel for any Service Recipient; (iii) exercise binding authority with respect to the operations of any Service Recipient; (iv) make binding recommendations to any Service Recipient; (v) make decisions or
have decision-making rights with respect to any Service Recipient; (vi) hold itself out as having the authority to bind or conclude contracts on behalf of any Service Recipient or (vii) perform Services for any Service Recipient that are
not covered by this Agreement except as mutually agreed. 

  

	3.3	 The Service Provider and its employees, subcontractors or agents shall have the authority, in connection
with the provision of the Services to a Service Recipient, to, (i) provide advice, assistance, and recommendations to each such Service Recipient with respect to the operation of the business of the Service Recipient; (ii) make
recommendations on key points of contracts; (iii) 

  
 4 

 participate in discussions on contracts and agreements; (iv) arrange
transactions between each such Service Recipient and other parties, provided that the Service Provider does not make any actual, binding decisions for the Service Recipient; and (v) contact banks in connection with raising capital for each such
Service Recipient. Each Service Recipient reserves the right to make all decisions with regard to such matters upon which the Service Provider has rendered advice, assistance, or recommendations. 

 

	3.4	 Engagement of Third Parties. For purposes of performing Services under this Agreement, the Service
Provider may engage such Persons (including employees, consultants, clinical research organizations, vendors and other Third Parties) as it deems necessary or desirable; provided, however, that the Service Provider shall remain
responsible for the performance of all such Services and shall be considered to engage with such Persons in its own name and on its own behalf. 

  

	3.5	 Use of Certain Systems. Each Service Recipient acknowledges and agrees that, in order to receive
certain of the Services, such Service Recipient may be required to use certain systems or technology that are the same as, that integrate with, or that are otherwise compatible with the systems and technology used by the Service Provider in
performing the Services. Each Service Recipient further acknowledges and agrees that in using such system or technology, it will abide by the policies and procedures established by Service Provider governing the use of that system and technology.
With respect to each Service requested by a Service Recipient, the Service Provider will notify the Service Recipient in writing of any such system and technological requirements. If, after reviewing the system and technological requirements, the
Service Recipient chooses to have Service Provider perform the requested Service, the Service Recipient shall implement such systems and/or technology at its sole expense. The Parties acknowledge and agree that, if a Service Recipient fails to
implement such systems and technology, then the Service Provider shall have no obligation to perform the applicable Services unless and until such Service Recipient implements such systems and technology. 

 

	4.	 FEES AND EXPENSES 

 

	4.1	 Each Service Recipient shall pay the Service Provider a fee in accordance with Exhibit B attached
hereto for the Services provided to such Service Recipient hereunder. The fees specified in Exhibit B attached hereto shall be reviewed and may be updated from time to time by the Parties. Fees for Services performed by the Service Provider
will be billed by the Service Provider to the applicable Service Recipient on a monthly basis. All other costs for Third Party services shall be billed, by or on behalf of the Service Provider, to the applicable Service Recipient, in such manner and
format and with such supporting information as the Parties may reasonably agree from time to time. Payment for undisputed invoices received by the applicable Service Recipient shall be due within sixty (60) days after the billing date. Any fees
and expenses not paid by the due date thereof shall accrue interest at the safe harbor interest rate based on the applicable Federal rate as set forth in U.S. Treasury Regulations
Section 1.482-2(a)(2)(iii)(B). All fees and expenses shall be invoiced and payable in U.S. dollars. 

  

	4.2	 Yearly Reconciliation. The Parties shall perform a yearly reconciliation for the compensation amounts
paid as follows: 

  

	 	a.	 Administrative Services Yearly Reconciliation. 

 

	 	i.	 As soon as reasonably practicable following the close of each Year during the Term of this Agreement, the
Parties will calculate the total service fee with respect to the activities listed in Exhibit A, subsection 1 (“Administrative and Support Services”) owing under this Agreement by each Service Recipient for the Year (the
“Exhibit B Administrative Services Fees”) by calculating the Service Provider’s Costs with 

  
 5 

	 	 respect to such Services provided to such Service Recipient and applying the mutually agreed mark-up percentage for such Services determined in accordance with Exhibit B, and adding the amount of any third-party costs reimbursable under Exhibit B paragraph (c) that relate to such
Services. As soon as reasonably practicable following the close of each Year, the Parties shall also calculate the total amount of service fees actually paid by such Service Recipient for the Year under Section 4.1 with respect to the
activities listed in Exhibit A, subsection 1 (“Administrative and Support Services”), adding the amount of any third-party costs reimbursable under Exhibit B paragraph (c) that relate to such Services (the
“Actual Administrative Services Fees”). 

  

	 	ii.	 If, for any Year, the total Actual Administrative Services Fees paid by a Service Recipient is greater than
the Exhibit B Administrative Services Fees for such Service Recipient, there shall be deemed to exist an excess of service fee in an amount equal to the difference between the total Actual Administrative Services Fees paid by such Service
Recipient and the total Exhibit B Administrative Services Fees for such Service Recipient for the Year (hereinafter “Administrative Services Excess”). 

 

	 	iii.	 If, for any Year, the total Actual Administrative Services Fees paid by a Service Recipient is less than the
total Exhibit B Administrative Services Fees for such Service Recipient, there shall be deemed to exist a shortfall in an amount equal to the difference between the total Exhibit B Administrative Services Fees for such Service
Recipient and the total Actual Administrative Services Fees paid by such Service Recipient (hereinafter “Administrative Services Shortfall”). 

 

	 	b.	 Other Services Yearly Reconciliation. 

 

	 	i.	 As soon as reasonably practicable following the close of each Year during the Term of this Agreement, the
Parties will calculate the total service fee with respect to the activities listed in Exhibit A, subsection 2 (“Other Services”) owing under this Agreement by each Service Recipient for the Year (the “Exhibit B Other
Services Fees”) by calculating the Service Provider’s Costs with respect to such Services provided to such Service Recipient and applying the mutually agreed mark-up percentage for such Services
determined in accordance with Exhibit B, and adding the amount of any third-party costs reimbursable under Exhibit B paragraph (c) that relate to such Services. As soon as reasonably practicable following the close of each Year,
the Parties shall also calculate the total amount of service fees actually paid by each Service Recipient for the Year under Section 4.1 with respect to the activities listed in Exhibit A, subsection 1 (“Other Services”),
adding the amount of any third-party costs reimbursable under Exhibit B paragraph (c) that relate to such Services (the “Actual Other Services Fees”). 

 

	 	ii.	 If, for any Year, the total Actual Other Services Fees paid by a Service Recipient is greater than the
Exhibit B Other Services Fees for such Service Recipient, there shall be deemed to exist an excess of service fee in an amount equal to the difference between the total Actual Other Services Fees paid by such Service Recipient and the total
Exhibit B Other Services Fees for such Service Recipient for the Year (hereinafter “Other Services Excess”). 

  
 6 

	 	iii.	 If, for any Year, the total Actual Other Services Fees paid by a Service Recipient is less than the total
Exhibit B Other Services Fees for such Service Recipient, there shall be deemed to exist a shortfall in an amount equal to the difference between the total Exhibit B Other Services Fees for such Service Recipient and the total Actual
Other Services Fees paid by such Service Recipient (hereinafter “Other Services Shortfall”). 

  

	 	c.	 Settlement of Excess or Shortfall Amounts. 

 

	 	i.	 If, for any Year, (1) the sum of the Administrative Services Shortfall for a Service Recipient and the
Other Services Shortfall for such Service Recipient exceeds (2) the sum of the Administrative Services Excess for such Service Recipient and the Other Services Excess for such Service Recipient (such excess amount, the “Net
Shortfall”), such Service Recipient shall pay such Net Shortfall to the Service Provider within thirty (30) days after the Exhibit B Administrative Services Fees, Exhibit B Other Services Fees, Actual Administrative
Services Fees, and Actual Other Services Fees have been calculated for such Year. 

  

	 	ii.	 If, for any Year, (1) the sum of the Administrative Services Excess for a Service Recipient and the
Other Services Excess for such Service Recipient exceeds (2) the sum of the Administrative Services Shortfall for such Service Recipient and the Other Services Shortfall for such Service Recipient (such excess amount, the “Net
Excess”), the Service Provider shall treat such Net Excess, in whole or in part, as an overpayment to the Service Provider that must be repaid to such Service Recipient within thirty (30) days after the end of the Year.

  

	4.3	 Withholding. The Service Recipients shall be entitled to deduct from any payments to the Service
Provider the amount of any withholding taxes with respect to such amounts payable, or any taxes in each case required to be withheld by the applicable Service Recipient to the extent that such Service Recipient pays to the appropriate Government
Authority on behalf of the Service Provider such taxes, levies, or charges. Such Service Recipient shall, upon the request of the Service Provider, deliver to the Service Provider proof of payment of all such taxes, levies, and other charges and the
appropriate documentation that is necessary to obtain a tax credit, to the extent such tax credit can be obtained. 

  

	5.	 ACCESS TO BOOKS AND RECORDS 

The Service Provider shall maintain books and records pertaining to the Services provided in any Year pursuant to this
Agreement for ten (10) Years following the performance of such Services and shall make them available for inspection and audit, at the applicable Service Recipient’s expense, by a mutually acceptable independent certified public accounting
firm during normal business hours upon reasonable prior written notice to the Service Provider. 
  

	6.	 CONFIDENTIAL INFORMATION 

 

	6.1	 Obligations. The Parties acknowledge that, from time to time, one Party (the “Disclosing
Party”) may disclose to another Party (the “Receiving Party”) Confidential Information. The Receiving Party shall retain such Confidential Information in confidence and shall not disclose such Confidential Information to
any Third Parties other than: 

  

	 	a.	 in connection with the performance or receipt of the Services, as applicable; 

 

	 	b.	 in connection with the purposes or activities contemplated in (i) this Agreement or (ii) any other
written agreement entered into by and between the Parties; or 

  
 7 

	 	c.	 to the Receiving Party’s or its Affiliates’ Representatives, provided that such Persons owe an
obligation of confidence to the Receiving Party that is no less protective than the terms and conditions contained herein. 

The Receiving Party shall remain liable for the unauthorized uses and disclosures by its Representatives of the Disclosing
Party’s Confidential Information. The Receiving Party’s obligations under this section 6.1 will survive the termination of this Agreement. To the extent necessary to facilitate the sharing of data and information between the Parties, the
Parties shall enter into an information sharing agreement on mutually agreed terms and conditions. In the event of a conflict between the terms of such information sharing agreement and this Agreement, the terms of that Agreement shall govern. 

 

	6.2	 In the event that a Receiving Party or its Representatives are required by any governmental,
quasi-governmental or regulatory entity, any judicial body or any legal process to disclose any Confidential Information, the Receiving Party shall provide the Disclosing Party with prompt notice of any such requirement (unless prohibited by
applicable law, rule or regulation or the entity, body or process requiring such disclosure) so that the Disclosing Party may in its sole discretion seek a protective order or other appropriate remedy, each at the Disclosing Party’s sole
expense, and/or waive compliance with the provisions of this Agreement. If, in the absence of a protective order or other remedy or the receipt of a waiver by the Disclosing Party, the Receiving Party or any of its Representatives are nonetheless,
as advised by counsel, legally compelled to disclose Confidential Information, the Receiving Party and its Representatives may, without liability hereunder, disclose only that portion of Confidential Information or discussion information related to
Confidential Information which such counsel advises the Receiving Party or its Representatives is legally required to be disclosed, provided that, upon request by the Disclosing Party, the Receiving Party shall use commercially reasonable
efforts to preserve the confidentiality of Confidential Information, including, without limitation, by cooperating with the Disclosing Party at the Disclosing Party’s sole expense to obtain an appropriate protective order or other reliable
assurance that confidential treatment will be accorded Confidential Information upon such required disclosure. Notwithstanding anything in this Agreement to the contrary, either Party and its Representatives may disclose Confidential Information,
without notice, a protective order or other remedy solely where such disclosure is in connection with a routine audit or examination by, or a blanket document request from, a regulatory or self-regulatory authority, bank examiner or auditor that
does not reference the other Party provided that the auditor is advised of the confidential nature of the Confidential Information. 

  

	6.3	 Exceptions. Notwithstanding anything to the contrary contained herein, the term Confidential
Information shall not include information that, and nothing in this Agreement shall prevent the disclosure by the Receiving Party, or its Representatives of Confidential Information that: 

 

	 	a.	 Prior to the transmittal thereof to the Receiving Party was of general public knowledge;

  

	 	b.	 Becomes, subsequent to the time of transmittal to the Receiving Party, a matter of general public knowledge
otherwise than as a consequence of a breach by the Receiving Party of any obligation under this Agreement; 

  

	 	c.	 Is made public by the Disclosing Party; 

 

	 	d.	 Was in the possession of the Receiving Party or its Representatives in documentary form prior to the time of
disclosure thereof to the Receiving Party by the Disclosing Party, and is held by Receiving Party free of any obligation of confidence to the Disclosing Party or any Third Party; 

  
 8 

	 	e.	 Is received in good faith from a Third Party who, to the best of the Receiving Party’s knowledge, did
not obtain the same from the Disclosing Party and who imposed no obligation of secrecy on the Receiving Party with respect to such information; or 

  

	 	f.	 Can be demonstrated to be independently developed by the Receiving Party or its Representatives without use
or benefit of or reference to the Confidential Information. 

  

	6.4	 No Unauthorized Use. The Receiving Party shall refrain from using or exploiting any and all
Confidential Information for any purposes or activities other than in connection with: 

  

	 	a.	 the performance or receipt of the Services, as applicable; 

 

	 	b.	 those purposes or activities contemplated in (i) this Agreement or (ii) any other written
agreement entered into by and between the Parties; 

  

	 	c.	 corporate or financial transactions, including securing financing, any contemplated merger, acquisition, or
sale of all or substantially all of the Receiving Party’s business, equity or assets, or an initial public offering of, or any investment in, the Receiving Party provided that any use thereof is subject to obligations of confidence that are no
less protective than the terms and conditions contained herein; or 

  

	 	d.	 the Receiving Party’s compliance with any obligations imposed on Receiving Party under applicable law
or by any Government Authority. 

 For clarity, the Receiving Party may use the Disclosing Party’s
Confidential Information for the purposes or activities contemplated in (a) to (d) above. 
  

	6.5	 Residuals. Notwithstanding anything to the contrary in this Agreement regarding Confidential
Information, neither Party nor its Affiliates (including its employees, subcontractors, consultants and agents) shall be prohibited or enjoined from utilizing general knowledge, skills and experience, concepts,
know-how and techniques retained in the unaided memory of an individual and acquired as a result of such individual’s authorized access to the other Party’s Confidential Information during the course
of the performance or receipt of the Services provided that none of such retained general knowledge, skills and experience, concepts, know-how and techniques include any trade secrets of the other Party.

  

	6.6	 Survival. The Parties’ obligations under this Article 6 shall survive the termination of
this Agreement for any reason whatsoever. 

  

	7.	 OWNERSHIP OF AND LICENSE TO SERVICE RECIPIENT WORKS 

 

	7.1	 Ownership. The Service Provider agrees that all right, title and interest in and to any and all
Service Recipient Works will be owned exclusively by the applicable Service Recipient immediately and automatically upon creation, authoring, composition, or invention thereof. All Service Recipient Works, as applicable, shall be considered
“works made for hire” to the extent permitted under applicable copyright law and will be considered the sole property of the Service Recipients immediately and automatically upon creation, authoring, composition, or invention thereof. To
the extent such Service Recipient Works are not considered “works made for hire,” the Service Provider hereby assigns to the applicable Service Recipient, and the applicable Service Recipient hereby receives, all of the Service
Provider’s entire right, title, and interest to such Service Recipient Works, including all copyrights, patents and trade secrets therein, effective immediately and automatically upon creation, authoring, composition, or invention thereof. The
Service Provider agrees, at the applicable Service Recipient’s expense, to execute any documents reasonably requested by such Service Recipient or any successor in interest to such Service 

  
 9 

 Recipient, at any time in relation to such assignment. The Service Provider
further acknowledges and agrees that any and all derivative works, developments, or improvements based on the Service Recipient Works that also constitute Service Recipient Works, shall also be deemed Service Recipient Works and all right, title and
interest therein shall be exclusively owned by the applicable Service Recipient pursuant to the foregoing immediately and automatically upon creation, authoring, composition, or invention thereof. The Service Provider shall cooperate with the
applicable Service Recipient and any of its Affiliates, at the applicable Service Recipient’s expense (whether during or after the term of this Agreement), in the confirmation, registration, protection and enforcement of the rights and property
of the Service Recipients and their successors in interest in such Service Recipient Works. The Service Provider shall not at any time do or cause to be done, or fail to do or cause to be done, any act or thing, directly or indirectly, contesting or
in any way impairing any Service Recipient’s right, title, or interest in the Service Recipient Works. Every use of any Service Recipient Works (and any derivative works, developments, or improvements based on the Service Recipient Works) by
the Service Provider shall inure to the benefit of the applicable Service Recipient. For clarity, notwithstanding anything contained herein to the contrary, exclusive ownership of any Works other than Service Recipient Works vests in and remains
with the Service Provider, and the Service Provider has and shall retain all right, title and interest in and to all such Works (including all General Works). To the extent that any such Works (including General Works) are incorporated into or
otherwise required to use or exploit any Service Recipient Works, Service Provider agrees to grant and hereby grants, and will cause its Affiliates to grant, the Service Recipients a perpetual, worldwide, irrevocable, fully paid-up, royalty-free, transferrable, sublicensable, non-exclusive license under such Works to use, execute, reproduce, display, perform, distribute, prepare derivative works
of and otherwise exploit all Service Recipient Works provided, or required to be provided, by Service Provider to the Service Recipients under this Agreement. 
  

	7.2	 License. Each of the Service Recipients hereby grants to the Service Provider a non-exclusive, royalty-free, fully-paid up, worldwide right and license, subject to section 12.1, to all intellectual property rights therein or arising therefrom (a) to use the Service Recipient Works
and any other intellectual property provided by each such Service Recipient to the Service Provider solely in connection with the performance of the Services under this Agreement; and (b) notwithstanding anything contained herein to the
contrary, to use any and all data provided to, accessed by, or collected by the Service Provider, in whole or in part, in performing the Services (including any data in any Service Recipient Works or Confidential Information) for analytics purposes
and/or for purposes of improving or enhancing any of the Services or the operation of the business of the Service Provider generally (including any other Services of the Service Provider); provided, however, that any data that constitutes the
Confidential Information of any Service Recipient must be anonymized, de-identified or aggregated, subject to policies that are consistent with the applicable data privacy and security laws – which
policies are reasonably acceptable to Service Recipient. Furthermore, Service Provider shall not distribute such data externally without the prior consent of the Service Recipient. The Service Provider agrees that all uses of any Marks included in
the Service Recipient Works pursuant to this license are subject to and shall comply with Article 8 hereof. The rights and license granted in this Section 7.2 may be sublicensed, assigned or otherwise transferred to Affiliates of Service
Provider which provide Services to Service Provider in furtherance of the purposes and activities contained herein, in connection with the performance of Services or as a result of a merger, acquisition, sale of all or substantially all of the
Service Provider’s business, equity or assets or other business combination. 

  
 10 

	8.	 USE OF TRADEMARKS 

Each of the Service Recipients hereby grants the Service Provider a right to use its respective Marks only in connection with
the Services, provided that if any Service Recipient provides the Service Provider with reasonable written trademark guidelines governing the use of such Service Recipient’s Marks (which guidelines may be updated by such Service Recipient from
time to time with prior reasonable written notice to the Service Provider), the Service Provider’s use of such Marks shall be subject to such written guidelines so provided. Notwithstanding the foregoing, the Service Provider will comply with
all of the Service Recipients’ reasonable instructions and quality control requirements regarding the Service Provider’s use of such Service Recipients’ Marks. The Service Provider acknowledges that the Service Recipients’ Marks,
as between the Service Provider and Service Recipients, are owned and licensed solely and exclusively by the Service Recipients, and agrees to use such Marks only in the form and with appropriate legends as described by the applicable Service
Recipients. All use of the Service Recipients’ Marks and associated goodwill will inure to the benefit of the applicable Service Recipients. All rights not expressly granted are reserved to the applicable Service Recipients. The Service
Provider shall not remove, cover, or modify any proprietary rights notice or legend placed by the other party on materials used in connection with this Agreement. 
  

	9.	 DERMAVANT DISCLOSURES; ETC. 

 

	9.1	 The Service Recipients shall have ultimate authority over, and complete and total responsibility for, any
and all Dermavant Disclosures. For the avoidance of doubt, this includes all decisions regarding (i) whether to make or not make a Dermavant Disclosure; (ii) the contents of any Dermavant Disclosure; or (iii) whether any Dermavant
Disclosure is complete, accurate, or complies with applicable legal requirements. 

  

	9.2	 The Service Provider shall have no authority over or responsibility for any Dermavant Disclosure. For the
avoidance of doubt, the Service Provider will not (and will not have the authority to): (i) approve or certify the accuracy or completeness of any Dermavant Disclosure; (ii) make any public statements or disclosures on behalf of any Service
Recipient; (iii) make, or provide any advice for the Service Recipients to make, any decisions regarding when a Dermavant Disclosure is required or whether any Dermavant Disclosure complies with applicable law. 

 

	9.3	 The Service Provider has no authority to make any statements or disclosure on behalf of any Service
Recipient in the disclosures of the Service Recipient, and no Service Recipient will attribute any statements in any Dermavant Disclosure to the Service Provider or any of the Service Provider’s employees (except to the extent the employee is
an officer, director or employee of Service Recipient and then only in such employee’s capacity as an officer, director or employee of Service Recipient). 

 

	9.4	 Third-Party Information and U.S. Defend Trade Secrets Act. 

 

	 	a.	 During the Term and thereafter, neither Party will improperly use or disclose to the other any confidential,
proprietary or secret information of such Party’s former clients or any other person, and such Party will not bring any such information onto the other Party’s property or place of business. 

 

	 	b.	 Notwithstanding the foregoing, the U.S. Defend Trade Secrets Act of 2016 (“DTSA”) provides
that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) in confidence to a federal, state, or local government official, either directly
or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (iii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under
seal. In addition, DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in
the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order. 

  
 11 

	10.	 CERTAIN REGULATIONS 

 

	10.1	 Reporting of Compensation. 

Consistent with the confidentiality obligations under this Agreement, Service Recipient reserves the right to make reports to
applicable government agencies disclosing information associated with any compensation paid under this Agreement in order to comply with applicable laws, which information may be published on government records available to the public, including the
EDGAR electronic filing system of the United States Securities and Exchange Commission. 
  

	10.2	 Insider Trading. 

Each of the Parties hereto acknowledges that it and its Representatives may in connection with this Agreement become aware of
material non-public information regarding the other Parties hereto, and that national, provincial and state securities laws prohibit each such Party and its Representatives and their immediate families from
purchasing or selling any securities on the basis of such material non-public information and from assisting any others to do so. Each Party agrees that it shall not violate and shall inform its
Representatives that they and their immediate family members must not violate any applicable law or regulation bearing on trading in securities of the other Parties hereto. 
  

	11.	 COOPERATION REGARDING THE PHARMACEUTICAL QUALITY SYSTEM AND COMPLIANCE 

 

	11.1	 To the extent that the Service Recipient seeks Services related to its quality management systems, the
Parties agree to cooperate and coordinate as appropriate concerning the quality systems, to enter into a Quality Agreement, and to adopt, implement and maintain at all times while this Services Agreement is in effect, quality standards, as
periodically updated, that are consistent with (and no less restrictive than) the Service Provider’s quality standards; provided that such Service Provider quality standards are reasonably necessary or appropriate to comply with applicable
rules and industry regulations. 

  

	11.2	 Each Party further agrees to notify the other Parties if it identifies any quality systems or compliance
issues that could reasonably expected to adversely impact the provision or receipt of Services or performance under the provisions of this Agreement, and to cooperate and coordinate as appropriate in addressing any such issues.

  

	12.	 INDEMNIFICATION; LIMITATION OF LIABILITY 

 

	12.1	 Service Provider Indemnity. The Service Provider, to the maximum extent permitted by law, shall
defend, protect, indemnify and hold the Service Recipients and their officers, employees and directors, as the case may be (“Recipient Indemnified Parties”), harmless from and against any and all losses, demands, damages,
liabilities, interest, awards, judgments, settlements and compromises relating to any Third Party claims, actions or causes of action, or suits, and all reasonable attorney’s fees and other fees and expenses in connection therewith
(“Losses”) which may be incurred by a Recipient Indemnified Party, arising out of, due to, or in connection with, directly or indirectly, the provision of the Services, except to the extent that such Losses are the result of:

  

	 	a.	 the combination of the Services with any other product or service; 

  
 12 

	 	b.	 any technology, materials, information, directions, or specifications provided by such Recipient Indemnified
Party or the performance of the Services in accordance with the foregoing; 

  

	 	c.	 any conduct requested or instructed by such Recipient Indemnified Party; or 

 

	 	d.	 the gross negligence or willful misconduct of such Recipient Indemnified Party. 

 

	12.2	 Service Recipient Indemnity. Each Service Recipient, to the maximum extent permitted by law,
shall defend, protect, indemnify and hold the Service Provider and its Affiliates and each of their officers, employees and directors, as the case may be (“Provider Indemnified Parties”), harmless from and against any and all
Losses which may be incurred by a Provider Indemnified Party, arising out of, due to, or in connection with, directly or indirectly, the receipt of the Services by the Service Recipient, except to the extent that either: (a) such Losses are the
result of the gross negligence or willful misconduct of such Provider Indemnified Party, or (b) such Losses are indemnifiable under Section 12.1 (Service Provider Indemnity). 

 

	12.3	 The Service Provider’s aggregate liability under this Agreement for any cause whatsoever, and
regardless of the form of action, whether in contract or in tort, shall be limited to the payments made by the applicable Service Recipient under this Agreement for the specific Service that allegedly caused or was related to the Losses during the
twelve (12) month period prior to the date the Losses were first incurred. In no event shall the Service Provider be liable for any Losses caused by any Service Recipient’s failure to perform its obligations under this Agreement.

  

	12.4	 NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT OR AT LAW OR IN EQUITY AND EXCEPT TO THE EXTENT
THAT ANY THIRD PARTY IS CONTRACTUALLY OBLIGATED TO AND DOES INDEMNIFY THE LIABLE PARTY THEREFOR AND SUCH REMEDIES MAY BE PASSED THROUGH TO THE OTHER PARTY, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR PUNITIVE, SPECIAL, INDIRECT, INCIDENTAL OR
CONSEQUENTIAL DAMAGES TO THE OTHER PARTY OR ANY OTHER PERSON (INCLUDING DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, ACTIONS OF THIRD PARTIES OR ANY OTHER LOSS) ARISING FROM OR RELATING TO ANY CLAIM MADE UNDER THIS AGREEMENT OR THE
PERFORMANCE OR THE FAILURE TO PERFORM THE SERVICES. 

  

	13.	 TERM AND TERMINATION 

 

	13.1	 Term. This Agreement shall commence on the Effective Date and continue until terminated by a Party in
accordance with this Section 13.1 (the “Term”). The Service Provider may terminate this Agreement at its discretion by giving written notice to the Service Recipients at least ninety (90) days before the
proposed termination date. Each Service Recipient may terminate this Agreement solely with respect to itself at its discretion by giving written notice to the Service Provider at least ninety (90) days before the proposed termination
date. Article 1, Article 5, Article 6, Article 7, Section 9.4, Article 10, Article 12, Section 13.2 and Article 15 shall survive the termination of this Agreement. Each Service
Recipient hereby specifically agrees and acknowledges that all obligations of the Service Provider to provide any and all Services shall immediately cease upon termination of this Agreement. The Service Provider hereby specifically agrees and
acknowledges that all of its rights to use Marks pursuant to Article 8 of this Agreement shall cease after a reasonable and mutually-agreed wind-down period commencing upon termination of this Agreement. To the extent permitted by applicable
law, no Party shall be liable to another Party for, and each Party hereby expressly waives any right to, any termination compensation of any kind or character whatsoever, to which such Party may be entitled solely by virtue of termination of this
Agreement. 

  
 13 

	13.2	 Rights and Duties on Termination. Upon termination of this Agreement for any reason, each Party shall
cease all use of the other Parties’ Confidential Information, and the Service Recipients shall pay the Service Provider all accrued and unpaid fees for Services performed through the date of termination. 

 

	14.	 COMPLIANCE WITH LAWS 

 

	14.1	 General Compliance. The Parties shall at all times strictly comply with all applicable laws, rules,
regulations, and governmental orders, now or hereafter in effect, relating to their performance of this Agreement. Each Party further agrees to make, obtain, and maintain in force at all times during the term of this Agreement, all filings,
registrations, reports, licenses, permits, and authorizations (collectively, “Authorizations”) required under applicable law, regulation, or order for such Party to perform its obligations under this Agreement. Each Service
Recipient shall provide the Service Provider with such assistance as the Service Provider may reasonably request in making or obtaining any such Authorizations. 

 

	15.	 GENERAL PROVISIONS 

 

	15.1	 Notices. Any and all notices, elections, offers, acceptances, and demands permitted or required to be
made under this Agreement shall be in writing, signed by the Party giving such notice, election, offer, acceptance, or demand and shall be delivered personally, by messenger, courier service, telecopy, first class mail or similar transmission, to
the Party, at its address on file with the Party giving such notice, election, offer, acceptance or demand or at such other address as may be supplied in writing. The date of personal delivery or the date of mailing, as the case may be, shall be the
date of such notice, election, offer, acceptance, or demand. 

  

	15.2	 Force Majeure. If the performance of any part of this Agreement by a Party, or of any obligation
under this Agreement (other than an obligation to pay money), is prevented, restricted, interfered with, or delayed by reason of any cause beyond the reasonable control of the Party liable to perform, unless conclusive evidence to the contrary is
provided, the Party so affected shall, on giving written notice to the other Parties, be excused from such performance to the extent of such prevention, restriction, interference, or delay, provided that the affected Party shall use its reasonable
efforts to avoid or remove such causes of nonperformance and shall continue performance with the utmost dispatch whenever such causes are removed. When such circumstances arise, the Parties shall discuss what, if any, modification of the terms of
this Agreement may be required in order to arrive at an equitable solution. 

  

	15.3	 Successors and Assigns. This Agreement may not be assigned or otherwise conveyed by any Party without
the prior written consent of the other Parties; provided however that such prior written consent will not be required for an assignment to an Affiliate of a Party. This Agreement shall be binding on and inure to the benefit of the Parties hereto and
their respective successors, successors in title and assigns to the extent that such assignment is permitted under this paragraph. 

  

	15.4	 Entire Agreement, Amendments. This Agreement constitutes the entire agreement between the Parties
with respect to the subject matter hereof, and supersedes all prior agreements, understandings, and communications between the Parties, whether oral or written, relating to the same subject matter. No change, modification, or amendment of this
Agreement shall be valid or binding on the Parties unless such change or modification shall be in writing signed by the Party or Parties against whom the same is sought to be enforced. 

 

	15.5	 Remedies Cumulative. The remedies of the Parties under this Agreement are cumulative and shall not
exclude any other remedies to which the Party may be lawfully entitled. 

  
 14 

	15.6	 Other Persons. Nothing in this Agreement shall be construed to prevent or prohibit the Service
Provider from providing services to any other Person or from engaging in any other business activity. 

  

	15.7	 Not for the Benefit of Third Parties. This Agreement is for the exclusive benefit of the Parties to
this Agreement and not for the benefit of any Third Party. 

  

	15.8	 Further Assurances. Each Party hereby covenants and agrees that it shall execute and deliver such
deeds and other documents as may be required to implement any of the provisions of this Agreement. 

  

	15.9	 No Waiver. The failure of any Party to insist on strict performance of a covenant hereunder or of any
obligation hereunder shall not be a waiver of such Party’s right to demand strict compliance therewith in the future, nor shall the same be construed as a novation of this Agreement. 

 

	15.10	 Integration. This Agreement constitutes the full and complete agreement of the Parties.

  

	15.11	 Captions. Titles or captions of articles and paragraphs contained in this Agreement are inserted only
as a matter of convenience and for reference, and in no way define, limit, extend, or describe the scope of this Agreement or the intent of any provision hereof. 

 

	15.12	 Construction. Whenever required by the context, the singular number shall include the plural, the
plural number shall include the singular, and the gender of any pronoun shall include all genders. If a term is defined as one part of speech (such as a noun), it shall have a corresponding meaning when used as another part of speech (such as a
verb). The term “includes” or “including” shall mean “including without limitation.” The words “hereof,” “hereto,” “hereby,” “herein,” “hereunder” and words of similar
import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular section or article in which such words appear. The use of “or” is not intended to be exclusive unless expressly indicated otherwise.

  

	15.13	 Counterparts. This Agreement may be executed in multiple copies, each one of which shall be an
original and all of which shall constitute one and the same document, binding on the Parties, and each Party hereby covenants and agrees to execute all duplicates or replacement counterparts of this Agreement as may be required.

  

	15.14	 Governing Law; Arbitration. This Agreement shall be governed by, and construed and enforced in
accordance with, the Laws of the State of New York, without regard to the provisions governing conflict of laws. Any dispute, controversy or claim between the Parties to this Agreement, including any claim arising out of, in connection with, or in
relation to the interpretation, performance, breach, or termination thereof, shall be resolved exclusively and finally by confidential binding arbitration. The seat, or legal place, of arbitration shall be New York, New York. The language of the
arbitration shall be English. The arbitration shall be administered by the International Centre for Dispute Resolution in accordance with its International Arbitration Rules in force when the Notice of Arbitration is submitted in accordance with
such Rules. Each Party shall select one person to act as arbitrator and the two selected shall select a third arbitrator, who shall act as president of the panel. Where there are multiple claimants or multiple respondents, the multiple claimants,
jointly, and the multiple respondents, jointly, shall select the party-appointed arbitrators. Except as may be required by law, to comply with a legal duty, or to pursue a legal right, neither a Party nor an arbitrator may disclose the existence,
content, or results of any arbitration hereunder without the prior written consent of the Parties. Nothing herein shall prevent a Party from seeking provisional measures from any court of competent jurisdiction, and any such request shall not be
deemed incompatible with the agreement to arbitrate or a waiver of the right to arbitrate. Each Party shall consent, for purposes of provisional measures or the enforcement of any 

  
 15 

	 	 arbitral award, to the non-exclusive jurisdiction of the state and
federal courts located in New York, New York, and each Party shall not assert that such courts constitute forum non-conveniens. The award shall be final and binding on the Parties. Judgment on the award may be entered in any court of competent
jurisdiction. 

  

	15.15	 Computation of Time. Whenever the last day for the exercise of any privilege or the discharge of any
duty hereunder shall fall on a Saturday, Sunday, or any public or legal holiday, whether local or national, the Party having such privilege or duty shall have until 5:00 p.m. (EST or, if in effect in New York, EDT) on the next succeeding business
day to exercise such privilege, or to discharge such duty. 

  

	15.16	 Severability. In the event any provision, clause, sentence, phrase, or word hereof, or the
application thereof in any circumstances, is held to be invalid or unenforceable, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder hereof, or of the application of any such provision, sentence,
clause, phrase, or word in any other circumstances. 

  

	15.17	 Costs and Expenses. Unless otherwise provided in this Agreement, each Party shall bear all fees and
expenses incurred in performing its obligations under this Agreement. 

  

	15.18	 Provisions of Law. A reference in this Agreement to a provision of law, regulation, rule, official
directive, request, or guideline (whether or not having the force of law) of any governmental, intergovernmental or supranational body, agency, department or regulatory, self-regulatory, or other authority or organization is a reference to that
provision as amended or re-enacted currently or in the future. 

  

	15.19	 Meaning in Notices. Unless a contrary indication appears, a term used in any notice given under or in
connection with this Agreement has the same meaning in that notice as in this Agreement. 

  

	15.20	 No Fiduciary Duties. Each Party shall not have any fiduciary obligations or duties to the other
Parties by reason of this Agreement. 

 (The remainder of this page has been intentionally left blank) 

  
 16 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to
be executed by their duly authorized officers, effective as of the date first above written. 
  

									
	DERMVANT SCIENCES GMBH	  		  	ROIVANT SCIENCES GMBH
					
	By:	 	 /s/ Sascha Bucher
	  		  	By:	 	 /s/ Sascha Bucher

	Title:	 	Head of Global Transactions	  		  	Title:	 	Head of Global Transactions
	Date:	 	August 20, 2018	  		  	Date:	 	August 20, 2018

 DSG – RSG Services Agreement Signature Page 

 EXHIBIT A 

SERVICES PROVIDED 
  

	1.	 Administrative and Support Services. Various administrative and supportive services, which may
include, but are not limited to: 

 (a) Payroll 

(b) Accounts Receivable 
 (c)
Accounts Payable 
 (d) General Administrative 

(e) Corporate and Public Relations (including advertising, investor relations and/or financial marketing) 

(f) Meeting Coordination and Travel Planning 

(g) Accounting and Auditing 
 (h)
Tax 
 (i) Budgeting 
 (j)
Treasury Activities 
 (k) Staffing and Recruiting 

(l) Training and Employee Development 

(m) Benefits 
 (n) Information and
Technology Services 
 (o) Legal Services (as may be specified by and subject to a separate letter entered into by Service Recipient and
specific lawyers of Service Provider) 
 (p) Insurance Claims Management 

(q) Purchasing 
 And other similar
services. 
  

	2.	 Other Services 

Administrative, research and development services whether provided directly or by engaging employees, agents, consultants, contract research
organizations, vendors or any other Third Party, including, but not limited to drug discovery and development from target identification through regulatory approval. 

Exhibit A to the DSG-RSG Services Agreement 

 EXHIBIT B 

CALCULATION OF COMPENSATION FOR SERVICES PROVIDED 

The fees set forth in this Exhibit B represent the entire amount to be paid by each Service Recipient in connection
with the Service Provider’s performance of the Services, and any and all other costs and expenses associated with the Services or the Agreement. In addition, the fees set forth in this Exhibit B include any and all applicable federal,
state or local sales or use tax payable in connection with the Services or the Agreement (the “Taxes”). The Service Provider and Service Recipient agree, to the extent appropriate under applicable tax laws, rules and regulations to work
together to attempt reasonably to minimize Taxes applicable to Services, including the use of exemption certifications, as appropriate. 

Except as otherwise agreed to by the Parties from time to time, the applicable Service Recipient shall compensate the Service
Provider for its Services rendered and Costs incurred under this Agreement in accordance with the following: 
  

	 	(a)	 The applicable Service Recipient shall reimburse the Service Provider for its Costs, excluding Third Party
costs as provided in (c), incurred in providing the Administrative and Support Services described in Exhibit A to such Service Recipient or in making, obtaining, and maintaining in force the Authorizations as described in
Section 14.1 for such Service Recipient and shall further pay the Service Provider a mark-up on such costs. The mark-up shall be based on the mark-up percentage that the Parties mutually agree is
consistent with the financial returns of independent companies performing similar services. The Parties shall review and (if necessary) update the mark-up percentage on an annual basis. 

 

	 	(b)	 The applicable Service Recipient shall reimburse the Service Provider for its Costs, excluding third-party
costs as provided in (c), incurred in providing the Other Services described in Exhibit A to such Service Recipient, and shall further pay the Service Provider a mark-up on such costs. The mark-up shall be based on the mark-up percentage that the Parties mutually agree is consistent with the financial returns of independent companies performing similar services.
The Parties shall review and (if necessary) update the mark-up percentage on an annual basis. 

  

	 	(c)	 If the Service Provider engages a Third Party pursuant to Section 3.4 hereof, the applicable
Service Recipient shall reimburse the Service Provider for all reasonable and actual out-of-pocket costs incurred by the Service Provider in connection with such engagement to the extent such Service Recipient is the beneficiary of the services
performed by such Third Party. 

 Exhibit B to the DSG-RSG Services Agreement 

  
 19EX-10.26

 Exhibit 10.26 

DERMAVANT SCIENCES, INC. 

EMPLOYMENT AGREEMENT 

This Employment Agreement (this “Agreement”) is entered into as of March 18, 2019, by and between Cyril Allouche
(the “Executive”) and Dermavant Sciences, Inc. (the “Company”). 
 RECITALS

 A. The Company desires the association and services of the Executive and his skills, abilities, background and knowledge, and
is willing to engage the Executive’s services on the terms and conditions set forth in this Agreement. 
 B. The Executive
desires to be in the employ of the Company, and is willing to accept such employment on the terms and conditions set forth in this Agreement. 

C. This Agreement supersedes any and all prior and contemporaneous oral or written employment agreements or arrangements between the
Executive and the Company or any predecessor thereof. 
 AGREEMENT 

In consideration of the foregoing, the parties agree as follows: 

1. EMPLOYMENT BY THE COMPANY. 

1.1 Position; Duties. Subject to the terms and conditions of this Agreement, the Executive shall hold the position of Chief Financial
Officer. In this position, the Executive will have the duties and authorities normally associated with a Chief Financial Officer of a company. The Executive will report to, and be subject to the direction of, the Company’s Chief Executive
Officer. The Executive shall devote the Executive’s full business energies, interest, abilities and productive time to the proper and efficient performance of the Executive’s duties under this Agreement; provided, however,
that the Executive may devote reasonable periods of time to (a) serving on the board of directors of other corporations subject to the prior approval of the Company’s Board of Directors (the “Board”), and
(b) engaging in charitable or community service activities, so long as none of the foregoing additional activities materially interfere with the Executive’s duties under this Agreement. 

1.2 Service to Affiliates. It is understood and agreed that the Executive’s duties may include providing services to or for the
benefit of the Company’s affiliates, including, but not limited to, Dermavant Sciences Ltd. (the “Parent”), provided, that the Executive agrees that he will not provide any services from within the United States for the
Parent or any affiliate of the Parent that is organized in a jurisdiction outside the United States. The Executive will not become an employee of the Parent, and the Executive’s activities in respect of services to the Parent shall be strictly
ministerial and shall not involve conducting any of the Parent’s business activities from within the United States, including day-to-day management or other
operational activities of the Parent. 

  
 1 

 1.3 Policies and Procedures. The employment relationship between the parties shall be
governed by this Agreement and by the policies and practices established by the Company and/or its Board. In the event that the terms of this Agreement differ from or are in conflict with the Company’s policies or practices, this Agreement
shall govern and control. 
 1.4 Exclusive Employment; Agreement not to Compete. Subject to Section 1.1 and 1.2 above,
except with the prior written consent of the Board, the Executive will not during his employment with the Company undertake or engage in any other employment, occupation or business enterprise. During the Executive’s employment, the
Executive agrees not to acquire, assume or participate in, directly or indirectly, any position, investment or interest known by the Executive to be adverse or antagonistic to the Company, its business, or prospects, financial or otherwise, or in
any company, person, or entity that is, directly or indirectly, in competition with the business of the Company. Ownership by the Executive in professionally managed funds over which the Executive does not have control or discretion in investment
decisions, or, an investment of less than two percent (2%) of the outstanding shares of capital stock of any corporation with one or more classes of its capital stock listed on a national securities exchange or publicly traded on a national
securities exchange or in the over-the-counter market shall not constitute a breach of this Section. 

1.5 Start Date. The Executive’s employment with the Company shall commence on March 25, 2019 (the
“Start Date”).  
 2.
AT-WILL EMPLOYMENT. 
 The Executive’s
employment relationship with the Company is, and shall at all times remain, at-will. This means that either the Executive or the Company may terminate the employment relationship at any time, for any reason or
for no reason, with or without Cause (as defined below) or advance notice; provided, however, the Executive must provide the Company at least two (2) months’ advance written notice of the Executive’s intention to resign
from employment (except for a resignation for Good Reason, in which case such procedure shall be governed by the terms set forth in the definition of Good Reason) and the Company shall provide the Executive written notice in the event of a
termination of the Executive’s employment by the Company without Cause. 
 3. COMPENSATION AND
BENEFITS. 
 3.1 Salary. The Company shall pay the Executive a base salary at the annualized rate of $350,000.00
(or $13,461.53 per pay period) (the “Base Salary”), less payroll deductions and all required withholdings, payable in regular periodic payments in accordance with the Company’s normal payroll practices. The Base Salary
shall be prorated for any partial year of employment on the basis of a 365-day year. The Base Salary shall be subject to periodic review and may be adjusted from time to time in the Board’s discretion.
This position is classified as exempt from overtime. 

  
 2 

 3.2 Signing Bonus. The Company shall pay the Executive a one-time signing bonus of Fifty thousand dollars ($50,000) within sixty (60) days of the Executive’s Start Date (the “Signing Bonus”), less payroll deductions and all
required withholdings. If the Executive resigns from employment with the Company without Good Reason or the Company terminates the Executive’s employment for Cause, in each case prior to the first anniversary of the Start Date, the Executive
must repay to the Company a pro rata portion of the Signing Bonus representing the remainder of the period between the date of termination and the one year anniversary of the Start Date. If any repayment is due to the Company pursuant to this
Section, the Executive agrees that the amount of the repayment due is payable in full immediately via personal check or payroll deduction and the Executive agrees to permit the Company to deduct this amount from any monies or benefits due to the
Executive including wages, bonuses, reimbursements and/or expenses and any remaining amounts are the Executive’s responsibility, payable via personal check immediately but in no event later than thirty (30) days of the Executive’s
last day of employment with the Company. 
 3.3 Annual Performance Bonus. Each fiscal year, the Executive will be eligible to earn an
annual discretionary cash bonus (the “Annual Performance Bonus”) with a target bonus opportunity equal to 40% of the Executive’s Base Salary, based on the Board’s assessment of the
Executive’s individual performance and overall Company performance. The Executive’s initial eligibility for this bonus is the annual period commencing April 1, 2019. In order to earn and receive the Annual Performance Bonus, the
Executive must remain employed by the Company through and including the date on which the Annual Performance Bonus is paid, except as otherwise set forth in Section 5.1. The Annual Performance Bonus, if any, will be paid no later than thirty
(30) days following the end of the Company’s fiscal year (March 31st) or by April 30th. The determination of whether the Executive has earned a bonus and the amount thereof shall be determined by the Board (and/or a committee thereof) in
its sole discretion. The Board (and/or a committee thereof) reserves the right to modify the bonus criteria from year to year. 
 3.4
Equity. Subject to the terms of the Parent’s 2016 Equity Incentive Plan (the “Plan”) and approval of the grant by the board of directors of the Company and the board of directors of the Parent (the
“Parent Board”), the Executive will be granted an option to purchase 750,000 shares of Dermavant Sciences Ltd. common stock (the “Dermavant Award”). It is anticipated that
the Dermavant Award will be granted on the 20th day of the month (or the following business day if the 20th day is a weekend or holiday) or as soon as reasonably practicable thereafter following the commencement of the Executive’s employment
and will be subject to a 4-year vesting period, with (i) twenty-five percent (25%) of the Dermavant Award vesting on the one-year anniversary of the grant of the
Dermavant Award and (ii) the balance of the Dermavant Award vesting in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the grant of the Dermavant Award, provided the Executive is
employed by the Company on each such vesting date. The Dermavant Award will be governed by the Plan and other documents issued in connection with the grant and will expire and cease to be exercisable on the ten (10) year anniversary of the
grant of the Dermavant Award. Upon a Change of Control (as defined in the Plan), any unvested portion of the Dermavant Award shall immediately vest in full. 

  
 3 

 3.5 Benefits and Insurance. The Executive shall, in accordance with Company policy
and the terms of the applicable plan documents, be eligible to participate in benefits under any benefit plan or arrangement that may be in effect from time to time and made available to similarly situated Company executives (including, but not
limited to, being named as an officer for purposes of the Company’s Directors & Officers insurance policy). The Company reserves the right in its sole discretion to modify, add or eliminate benefits at any time. All benefits shall be
subject to the terms and conditions of the applicable plan documents, which may be amended or terminated at any time. The Executive shall be entitled to vacation each year, in addition to sick leave and observed holidays in accordance with the
policies and practices of the Company. Vacation may be taken at such times and intervals as the Executive shall determine, subject to the business needs of the Company. 

3.6 Expense Reimbursements. The Company will reimburse the Executive for all reasonable business expenses that the Executive incurs in
conducting his duties hereunder, pursuant to the Company’s usual expense reimbursement policies. Reimbursement will be made as soon as practicable following receipt from the Executive of reasonable documentation supporting said expenses. 

4. PROPRIETARY INFORMATION OBLIGATIONS. 

As a condition of employment, the Executive agrees to execute and abide by the Company’s Employee
Non-Disclosure and Inventions Assignment Agreement (“NDA”). 

5. TERMINATION OF EMPLOYMENT. 

5.1 Termination Without Cause Or Resignation For Good Reason. If the Executive’s employment with the Company is terminated without
Cause or the Executive resigns for Good Reason (as defined below), then the Company shall pay the Executive any earned but unpaid Base Salary and unused vacation accrued (if applicable) through the date of termination, at the rates then in effect,
less standard deductions and withholdings. In addition, if the Executive furnishes to the Company an executed waiver and release of claims in a form provided by the Company, which may include an obligation for the Executive to provide reasonable
transition assistance (the “Release”) that is nonrevocable prior to the Release Date (as defined below), and if the Executive allows the Release to become effective in accordance with its terms, then the
Executive shall receive an (i) an Annual Performance Bonus for the year of termination, payable at the same time that Annual Bonuses are paid to active employees of the Company, (ii) continued payments of the Executive’s Base Salary
for the nine (9) month period following termination, payable in equal installments in accordance with customary payroll practices, but no less frequently than monthly, and (iii) reimbursement for COBRA coverage for nine (9) months
following termination of employment, which shall be taxable to the Executive, to the extent required by applicable law. The installment payments set forth in the preceding clause (ii) shall commence within ten (10) days following the
Release Date and will be subject to required withholding; provided that, any amounts that would have otherwise been paid during the period between the Executive’s termination date and the first payment date in accordance with payroll practices
will be included in the first payment. 

  
 4 

 5.2 Termination or Resignation Following a Change of Control. If the Company
terminates the Executive’s employment without Cause or the Executive resigns for Good Reason within six (6) months following the closing date of a Change of Control (as defined in the Plan), the Company shall pay the Executive any earned
but unpaid Base Salary and unused vacation accrued (if applicable) through the date of termination, at the rates then in effect, less standard deductions and withholdings. In addition, if the Executive furnishes to the Company an executed waiver and
release of claims in the form substantially similar to that attached hereto as Exhibit A, with any changes that the Company determines are necessary to comply with applicable law (the “Release”), which Release is non-revocable prior to the Release Date (as defined below), and if the Executive allows the Release to become effective in accordance with its terms, then: (A) reimbursement by the Company of insurance coverage
under COBRA, subject to Executive’s election and period of eligibility for such coverage, until the earlier of nine (9) months from the date of the termination of employment, or until Executive becomes eligible to be covered under a
subsequent employer’s group health insurance, (B) the Executive shall receive an aggregate amount equal to nine (9) months of the Executive’s then-current Base Salary plus one hundred percent (100%) of the Executive’s
then-current target Annual Performance Bonus, payable in equal installments over the nine (9) month period following the date of the Executive’s termination in accordance with customary payroll practices, but no less frequently than
monthly, and (C) any unvested portion of the Executive’s Dermavant Award shall immediately vest in full, subject to any other applicable provisions of the Plan. Any payments required by this Section 5.2 shall commence within ten
(10) days following the Release Date and will be subject to required withholding. 
 5.3 Other Termination. If the Executive
resigns his employment at any time without Good Reason or the Executive’s employment is terminated by the Company at any time for Cause or due to death or Disability (as defined below), the Company shall pay the Executive (or his estate) any
Base Salary and any unused vacation accrued (if applicable) through the date of such resignation or termination, at the rates then in effect, less standard deductions and withholdings. The Company shall thereafter have no further obligations to the
Executive, except as may otherwise be required by law. 
 5.4 Definitions. For purposes of this Agreement, the following terms shall
have the following meanings: 
 (a) “Cause” shall mean the occurrence of any of the following, the
Executive’s: (i) conviction of, or plea of no contest to, any felony or any crime involving moral turpitude or dishonesty, (ii) participation in a fraud against the Company, (iii) willful and material breach of the Executive’s
duties and obligations under this Agreement or any other agreement between the Executive and the Company or its affiliates that has not been cured (if curable) within thirty (30) days after receiving written notice from the Board of such
breach, (iv) engagement in conduct that causes or is reasonably likely to cause material damage to the Company’s property or reputation, (v) material failure to comply with the Company’s Code of Conduct or other material policies, or
(vi) violation of any law, rule or regulation (collectively, “Law”) relating in any way to the business or activities of the Company or its subsidiaries or affiliates, or

  
 5 

 other Law that is violated during the course of the Executive’s performance of services hereunder that
results in the Executive’s arrest, censure, or regulatory suspension or disqualification, including, without limitation, the Generic Drug Enforcement Act of 1992, 21 U.S.C. § 335(a), or any similar legislation applicable in the United
States or in any other country where the Company intends to develop its activities. “Disability” shall mean the Executive’s inability to perform his duties and responsibilities hereunder, with or without reasonable
accommodation, due to any physical or mental illness or incapacity, which condition has continued for a period of 180 days (including weekends and holidays) in any consecutive 365-day period. 

(b) “Good Reason” shall mean the occurrence of any of the following events without the Executive’s
consent: (i) a material reduction of the Executive’s Base Salary as initially set forth herein or as the same may be increased from time to time, provided, however, that if such reduction occurs in connection with a
Company-wide decrease in executive officer team compensation, such reduction shall not constitute Good Reason provided that it is a reduction of a proportionally like amount or percentage affecting the entire executive team not to exceed 10%; (ii)
material reduction in the Executive’s authority, duties or responsibilities, as compared to the Executive’s authority, duties or responsibilities immediately prior to such reduction; or (iii) a change in the Executive’s principal
location of employment, resulting in an increase in the Executive’s one-way driving distance by more than fifty (50) miles from the Executive’s then current principal residence on file with the
Company; provided, however, any resignation by the Executive shall only be deemed for Good Reason pursuant to this definition if: (1) the Executive gives the Company written notice of the Executive’s intent to terminate for
Good Reason within sixty (60) days following the first occurrence of the condition(s) that he believes constitute(s) Good Reason, which notice shall describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty
(30) days following receipt of the written notice (the “Cure Period”); and (3) the Executive voluntarily terminates his employment within thirty (30) days following the end of the Cure Period.

 5.5 “Release Date” shall mean the date that is fifty-five (55) days following the date of the
Executive’s termination. 
 5.6 Effect of Termination. The Executive agrees that should his employment be terminated for
any reason, he shall be deemed to have resigned from any and all positions with the Company, including, but not limited to, his position on the Board and Parent Board, as applicable. 

5.7 Section 409A Compliance. 

(a) It is intended that any benefits under this Agreement satisfy, to the greatest extent possible, the exemptions from the
application of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), provided under Treasury Regulations Sections
1.409A-1(b)(4), and 1.409A-1(b)(9), and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so
exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A. For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulations 

  
 6 

 
Section 1.409A-2(b)(2)(iii)), the Executive’s right to receive any installment payments under this Agreement (whether severance payments, if any,
or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. A termination of employment shall not be deemed
to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the
meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a “resignation,” “termination,” “termination of employment” or like terms shall mean separation from service.
Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company at the time of a separation from service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i), and if any payments
or benefits that the Executive becomes entitled to under this Agreement on account of such separation from service are deemed to be “deferred compensation,” then to the extent delayed commencement of any portion of such payments or
benefits is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) and the related adverse taxation under Section 409A, such payments shall not be provided prior to the earliest of (i) the expiration of
the six-month period measured from the date of separation from service, (ii) the date of Executive’s death or (iii) such earlier date as permitted under Section 409A without the imposition
of adverse taxation. Upon the first business day following the expiration of such period, all payments deferred pursuant to this paragraph shall be paid in a lump sum, and any remaining payments due shall be paid as otherwise provided herein. No
interest shall be due on any amounts so deferred. 
 (b) With regard to any provision herein that provides for reimbursement of
costs and expenses or in-kind benefits, except as permitted by Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to
liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for
reimbursement, or in-kind benefits to be provided, in any other taxable year, and (iii) such payments shall be made on or before the last day of the Executive’s taxable year following the taxable
year in which the expense was incurred. The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any compensation under this Agreement constitutes deferred compensation subject to Code
Section 409A but does not satisfy an exemption from, or the conditions of, Code Section 409A. 
 5.8 Section 280G.

(a) If any payment or benefit (including payments and benefits pursuant to this Agreement) that the Executive would receive in
connection with a transaction (the “Transaction”) from the Company or otherwise (“Transaction Payment”) would (i) constitute a “parachute payment” within the meaning of
Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise
Tax”), then the Company shall cause to be determined, before any amounts of the Transaction Payment are paid to the Executive, which of the following two 

  
 7 

 
alternative forms of payment would result in the Executive’s receipt, on an after-tax basis, of the greater amount of the Transaction Payment
notwithstanding that all or some portion of the Transaction Payment may be subject to the Excise Tax: (1) payment in full of the entire amount of the Transaction Payment (a “Full Payment”), or
(2) payment of only a part of the Transaction Payment so that the Executive receives the largest payment possible without the imposition of the Excise Tax (a “Reduced Payment”). For purposes of determining
whether to make a Full Payment or a Reduced Payment, the Company shall cause to be taken into account the value of all applicable federal, state and local income and employment taxes and the Excise Tax (all computed at the highest applicable
marginal rate, net of the maximum reduction in federal income taxes which could be obtained from a deduction of such state and local taxes). If a Reduced Payment is made, (x) the Executive shall have no rights to any additional payments and/or
benefits constituting the Transaction Payment, and (y) reduction in payments and/or benefits shall occur in the manner that results in the greatest economic benefit to the Executive as determined in this paragraph. If more than one method of
reduction will result in the same economic benefit, the portions of the Transaction Payment shall be reduced pro rata. 
 (b)
Notwithstanding the foregoing, in the event that no stock of the Company is readily tradeable on an established securities market or otherwise (within the meaning of Section 280G of the Code) at the time of the Transaction, the Company
shall cause a vote of shareholders to be held to approve the portion of the Transaction Payments that equals or exceeds three times (3x) the Executive’s “base amount” (within the meaning of Section 280G of the Code) (the
“Excess Parachute Payments”) in accordance with Treas. Reg. §1.280G-1, and the Executive shall cooperate with such vote of shareholders, including the execution of
any required documentation subjecting the Executive’s entitlement to all Excess Parachute Payments to such shareholder vote. In the event that the Company does not cause a vote of shareholder to be held to approve all Excess Parachute Payments,
the provisions set forth in Section 5.7(a) of this Agreement shall apply. 
 (c) Unless the Executive and the Company otherwise
agree in writing, any determination required under this section shall be made in writing by the Company’s independent public accountants (the “Accountants”), whose determination shall be conclusive and binding upon the
Executive and the Company for all purposes. For purposes of making the calculations required by this section, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith
interpretations concerning the application of Sections 280G and 4999 of the Code. The Accountants shall provide detailed supporting calculations to the Company and the Executive as requested by the Company or the Executive. The Executive and the
Company shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this section. The Company shall bear all costs the Accountants may reasonably incur in
connection with any calculations contemplated by this section. 

  
 8 

 6. ARBITRATION. 

Except as otherwise set forth below in connection with equitable remedies, any dispute, claim or controversy arising out of or relating to
this Agreement or the Executive’s employment with the Company (collectively, “Disputes”), including, without limitation, any dispute, claim or controversy concerning the validity, enforceability, breach or termination of
this Agreement, if not resolved by the parties, shall be finally settled by arbitration in accordance with the then-prevailing Employment Arbitration Rules and Procedures of JAMS, as modified herein (“Rules”). The requirement
to arbitrate covers all Disputes (other than disputes which by statute are not arbitrable) including, but not limited to, claims, demands or actions under the Age Discrimination in Employment Act (including Older Workers Benefit Protection Act);
Americans with Disabilities Act; Civil Rights Act of 1866; Civil Rights Act of 1991; Employee Retirement Income Security Act of 1974; Equal Pay Act; Family and Medical Leave Act of 1993; Title VII of the Civil Rights Act of 1964; Fair Labor
Standards Act; Fair Employment and Housing Act; and any other law, ordinance or regulation regarding discrimination or harassment or any terms or conditions of employment. There shall be one arbitrator who shall be jointly selected by the parties.
If the parties have not jointly agreed upon an arbitrator within twenty (20) calendar days of respondent’s receipt of claimant’s notice of intention to arbitrate, either party may request JAMS to furnish the parties with a list of
names from which the parties shall jointly select an arbitrator. If the parties have not agreed upon an arbitrator within ten (10) calendar days of the transmittal date of such list, then each party shall have an additional five
(5) calendar days in which to strike any names objected to, number the remaining names in order of preference, and return the list to JAMS, which shall then select an arbitrator in accordance with the Rules. The place of arbitration shall be
New York, New York. By agreeing to arbitration, the parties hereto do not intend to deprive any court of its jurisdiction to issue a pre-arbitral injunction, including, without limitation, with respect to the
NDA. The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. §§ 1-16. Judgment upon the award of the arbitrator may be entered in any court of competent jurisdiction. The
arbitrator shall: (a) have authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b) issue a written statement
signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The Company shall
pay all administrative fees of JAMS in excess of $435 (a typical filing fee in court) and the arbitrator’s fees and expenses. Each party shall bear its or his own costs and expenses (including attorney’s fees) in any such arbitration and
the arbitrator shall have no power to award costs and attorney’s fees except as provided by statute or by separate written agreement between the parties. In the event any portion of this arbitration provision is found unenforceable by a court
of competent jurisdiction, such portion shall become null and void leaving the remainder of this arbitration provision in full force and effect. The parties agree that all information regarding the arbitration, including any settlement thereof,
shall not be disclosed by the parties hereto, except as otherwise required by applicable law. 

  
 9 

 7. GENERAL PROVISIONS. 

7.1 Representations and Warranties. 

(a) The Executive represents and warrants that the Executive is not restricted or prohibited, contractually or otherwise, from
entering into and performing each of the terms and covenants contained in this Agreement, and that the Executive’s execution and performance of this Agreement will not violate or breach any other agreements between the Executive and any other
person or entity. The Executive represents and warrants that the Executive is not subject to any confidentiality, non-competition agreement or any other similar type of restriction that could restrict in any
way the Executive’s hiring by the Company and the performance of the Executive’s expected job duties with the Company. 
 (b)
The Company and its affiliates do not wish to incorporate any unlicensed or unauthorized material, or otherwise use such material in any way in connection with, its and their respective products and services. Therefore, the Executive hereby
represents, warrants and covenants that he has not and will not disclose to the Company or its affiliates, use in their business, or cause them to use, any information or material which is a trade secret, or confidential or proprietary information,
of a third party, including, but not limited to, any former employer, competitor or client, unless the Company or its affiliates have a right to receive and use such information or material. 

(c) The Executive represents and warrants that the Executive is not debarred and has not received notice of any action or threat with
respect to debarment under the provisions of the Generic Drug Enforcement Act of 1992, 21 U.S.C. § 335(a) or any similar legislation applicable in the United States or in any other country where the Company intends to develop its activities.
The Executive understands and agrees that this Agreement is contingent on the Executive’s submission of satisfactory proof of identity and legal authorization to work in the United States, as well as verification of auditor independence. 

7.2 Advertising Waiver. The Executive agrees to permit the Company, and persons or other organizations authorized by the Company, to
use, publish and distribute advertising or sales promotional literature concerning the products and/or services of the Company in which the Executive’s name and/or pictures of the Executive appear. The Executive hereby waives and releases any
claim or right the Executive may otherwise have arising out of such use, publication or distribution. 
 7.3 Miscellaneous. This
Agreement, along with the NDA and any applicable equity awards that have been granted, constitutes the complete, final and exclusive embodiment of the entire agreement between the Executive and the Company with regard to its subject matter. It is
entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement replaces and supersedes in all
respects the Offer Letter between the Company and the Executive, dated March 6, 2019. This Agreement may not be modified or amended 

  
 10 

 
except in a writing signed by both the Executive and a duly authorized officer or member of the Board. This Agreement will bind the heirs, personal representatives, successors and assigns of both
the Executive and the Company, and inure to the benefit of both the Executive and the Company, and to his and its heirs, successors and assigns, except that the duties and responsibilities of the Executive are of a personal nature and shall not be
assignable or delegable in whole or in part by the Executive. The Company may assign its rights, together with its obligations hereunder, in connection with any merger, consolidation, or transfer or other disposition of all or substantially all of
its assets, and such rights and obligations shall inure to, and be binding upon, any successor to the Company or any successor to all or substantially all of the assets of the Company, which successor shall expressly assume such obligations. If any
provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable.
This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of New York as applied to contracts made and to be performed entirely within New York. Any ambiguity in this
Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and
facsimile signatures will suffice as original signatures. 

  
 11 

 IN WITNESS WHEREOF, the parties have
executed this Agreement as of the day and year first written above. 
  

			
	DERMAVANT SCIENCES, INC.
		
	By: 	 	/s/ Todd Zavodnick
		 	Name: Todd Zavodnick
		 	Title: Chief Executive Officer

  

	
	ACCEPTED AND AGREED:
	
	/s/ Cyril Allouche
	Cyril Allouche

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]